Skip to main content
. 2022 Feb;33(2):401–419. doi: 10.1681/ASN.2021050643

Table 5b.

Time to relapse: During the treatment period

Group No. of Patients No. of Patients with Relapse No. of Patients Censored Median (95% CI) (days) Hazard Ratio (95% CI)
MMF 39 11 28 not reached 0.280 (0.14 to 0.57)
Placebo 39 27 12 320.0 (266.0 to 460.0)